Ensign Peak Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Ensign Peak Advisors's AMGN Position: Q3 2026 in Review
Ensign Peak Advisors increased its Amgen (AMGN) stake by 12% in Q3 2026, buying an estimated $11.3M and bringing the position to 265,209 shares worth $112M. The position accounts for 0.18% of the portfolio, ranked #102.
Ensign Peak Advisors first reported a position in AMGN in Q4 2019 and has held it in 28 quarters since. The position peaked at $204M in Q3 2023. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Ensign Peak Advisors held 265,209 shares of Amgen worth $112M as of Q3 2026.
- Ensign Peak Advisors bought 28,280 Amgen shares in Q3 2026, an estimated $11.3M.
- Amgen made up 0.18% of Ensign Peak Advisors's portfolio in Q3 2026, its #102 holding.
- Ensign Peak Advisors first reported a position in Amgen in Q4 2019 and has held it in 28 quarters since.
- Ensign Peak Advisors's Amgen position peaked at $204M in Q3 2023.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.